Week On Wall Street
  • Home
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Skip to content
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Investor Tips
While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps.

Articles You May Like

How Rising AI Power Demand Is Fueling Utility ETFs
Brian’s Big Idea: Three Tech Stocks And A Popular Service at Zacks
Worried About an AI Bubble? Look to Surging International Stocks

Newsletter

Recent Articles

  • How Rising AI Power Demand Is Fueling Utility ETFs
  • Brian’s Big Idea: Three Tech Stocks And A Popular Service at Zacks
  • Worried About an AI Bubble? Look to Surging International Stocks
  • 5 Must See Earnings Charts That Aren’t Mag 7 Stocks
  • The Mag 7 Stock Charts: Which are Hot?
  • Is NextEra a Must-Buy AI Energy Stock Before Earnings?
  • Quantum Stocks Have Sold Off: Buy the Dip?
  • Top Stock Picks for Week of October 20, 2025
  • 5 Must-See AI Infrastructure Stock Charts
  • (no title) Post 51756

Earnings

  • Super Micro Computer shares surge 19% after company files delayed financials by deadline
  • Here’s why Home Depot remains a buy after retailer clears lowered earnings bar
  • Lucid CEO steps down; EV maker plans to more than double production in 2025
  • Workday beats estimates for revenue and profit, stock jumps
  • Chegg sues Google for hurting traffic with AI as it considers strategic alternatives

Business

  • Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
  • Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
  • Home Depot earnings beat Wall Street estimates, as retailer breaks comparable sales losing streak
  • How digitally native companies like Rothy’s are growing profitably in a new era for retail
  • Starbucks to lay off 1,100 corporate workers as sales sag

Useful Links

  • DMCA / Copyrights Disclaimer
  • Terms and Conditions
  • Whitelist Us
  • Privacy Policy

Copyright © 2025 by Week On Wall Street. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified.

Powered by WordPress using DisruptPress Theme.